19329192|t|Immune blood biomarkers of Alzheimer disease patients.
19329192|a|Alzheimer disease (AD) patients have an impairment of anti-amyloid-beta (Abeta) innate immunity and a defect in immune gene transcription [Fiala, M., Liu, P.T., Espinosa-Jeffrey, A., Rosenthal, M.J., Bernard, G., Ringman, J.M., Sayre, J., Zhang, L., Zaghi, J., Dejbakhsh, S., Chiang, B., Hui, J., Mahanian, M., Baghaee, A., Hong, P., Cashman, J., 2007b. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc. Natl. Acad. Sci. U. S. A. 104, 12849-12854]. Early diagnosis is a cornerstone of preventive approaches to AD. Phospho-tau and Abeta CSF levels are useful markers of neurodegeneration but not of a process leading to neurodegeneration. To detect an early biomarker of AD, we developed a flow cytometric test of Abeta phagocytosis, which was 94% positive (<400 MFI units) in AD patients (mean age+/-SEM 77+2.2 years; mean score+/-SEM 198.6+/-25.5 MFI units) and 60% positive in MCI patients (77+/-5.6 years; 301+/-106 MFI units). Control subjects, active senior university professors, were 100% negative (74.2+/-4.2 years; 1348+/-174 MFI units). The test had a low specificity in older caregivers and older amyotrophic lateral sclerosis (ALS) patients. We also tested transcriptional regulation of the genes MGAT-III and Toll-like receptor-3 in macrophages. Macrophages of "Type I" patients (a majority of patients) showed gene down regulation at baseline and up regulation by curcuminoids; macrophages of "Type II" patients showed opposite responses. The results of flow cytometric testing suggest that normal Abeta phagocytosis is associated with healthy cognition and lesser risk of AD. The significance of abnormal results in aged persons should be investigated by prospective studies to determine the risk of AD.
19329192	27	44	Alzheimer disease	Disease	MESH:D000544
19329192	45	53	patients	Species	9606
19329192	55	72	Alzheimer disease	Disease	MESH:D000544
19329192	74	76	AD	Disease	MESH:D000544
19329192	78	86	patients	Species	9606
19329192	113	126	-amyloid-beta	Gene	351
19329192	128	133	Abeta	Gene	351
19329192	482	501	Alzheimer's disease	Disease	MESH:D000544
19329192	502	510	patients	Species	9606
19329192	527	547	bisdemethoxycurcumin	Chemical	MESH:C034786
19329192	661	663	AD	Disease	MESH:D000544
19329192	673	676	tau	Gene	4137
19329192	681	686	Abeta	Gene	351
19329192	720	737	neurodegeneration	Disease	MESH:D019636
19329192	770	787	neurodegeneration	Disease	MESH:D019636
19329192	821	823	AD	Disease	MESH:D000544
19329192	864	869	Abeta	Gene	351
19329192	927	929	AD	Disease	MESH:D000544
19329192	930	938	patients	Species	9606
19329192	1030	1033	MCI	Disease	
19329192	1034	1042	patients	Species	9606
19329192	1259	1288	amyotrophic lateral sclerosis	Disease	MESH:D000690
19329192	1290	1293	ALS	Disease	MESH:D000690
19329192	1295	1303	patients	Species	9606
19329192	1373	1393	Toll-like receptor-3	Gene	7098
19329192	1434	1442	patients	Species	9606
19329192	1458	1466	patients	Species	9606
19329192	1529	1541	curcuminoids	Chemical	MESH:D036381
19329192	1568	1576	patients	Species	9606
19329192	1663	1668	Abeta	Gene	351
19329192	1738	1740	AD	Disease	MESH:D000544
19329192	1866	1868	AD	Disease	MESH:D000544
19329192	Negative_Correlation	MESH:C034786	MESH:D000544
19329192	Association	MESH:D000544	351
19329192	Positive_Correlation	MESH:D036381	7098
19329192	Association	MESH:D000544	7098

